Clinical Lymphoma, Myeloma & Leukemia is the official journal of the International Myeloma Society. CLML publishes original articles describing various aspects of clinical and translational research.
If you are interested in publishing clinical or translational research in Clinical Lymphoma, Myeloma & Leukemia, please contact a member of the myeloma editorial board.
Sundar Jagannath, MD
The Mount Sinai Hospital, New York, New York, United States of America
Sagar Lonial, MD
Emory University, Atlanta, Georgia, United States of America
Ajai Chari, MD | University of California, San Francisco, California, United States of America |
Mariateresa Fulciniti, PhD | Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America |
Morie Gertz, MD | Mayo Foundation for Medical Education and Research, Rochester, Minnesota, United States of America |
Amrita Krishnan, MD | City of Hope Beckman Research Institute, Duarte, California, United States of America |
Roberto Mina, MD | University Hospital City of Science and Health Turin, Torino, Italy |
Enrique Ocio, MD, PhD | University Hospital of Salamanca, Salamanca, Spain |
Evangelos Terpos, MD, PhD | National and Kapodistrian University of Athens, Athens, Greece |
Name | Affiliation/Location |
Meral Beksac, MD | Ankara, Turkey |
Wee Joo Chng, MD | Singapore |
Mattia D’Agostino, MD | Torino, Italy |
Michel Delforge, MD, PhD | Leuven, Belgium |
Hermann Einsele, MD | Würzburg, Germany |
Efstathios Kastritis, MD | Athens, Greece |
Xavier Leleu, MD, PhD | Poitiers, France |
Philippe Moreau, MD | Nantes, France |
E. Paola Neri, MD, PhD | Calgary, Alberta, Canada |
Charlotte Pawlyn, MD | London, United Kingdom |
Hang Quach, MD | Melbourne, Australia |
Karthik Ramasamy, MD | Oxford, United Kingdom |
Joshua Richter, MD | New York, New York, United States of America |
Fredrik Schjesvold, MD | Oslo, Norway |
Cyrille Touzeau, MD, PhD | Nantes, France |
Sonja Zweegman, MD, PhD | Amsterdam, Netherlands |
All members of IMS are entitled to a free online subscription to the Clinical Lymphoma, Myeloma & Leukemia.
Instructions to access and claim your subscription is as follows:
Step 1: Go to https://www.clinical-lymphoma-myeloma-leukemia.com/
Step 2: Click Log in and sign in using your credentials (Skip this and go to step 3 for first time registrants/users).
Step 3: Please click on Register at the top right corner of the home page. Enter your preferred e-mail address and all the requested details.
Step 4: Once registered and/or signed in, click Claim at the top right corner of the home page.
Step 5: Enter the code CLMLIMS on the Account Number field. Leave the ‘Last Name’ blank and do NOT tick ‘I receive a subscription as a Qualified Recipient of the US print edition’.
Step 6 : Click Activate Claim.
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.